Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amato L, Moretti S, Palleschi GM, Gallerani I, Franchi A, Fabbri P (2000) A case of angiosarcoma of the face successfully treated with combined chemotherapy and radiotherapy. Br J Dermatol 142: 822–823
Aust MR, Olsen KD, Lewis JE, Nascimento AG, Meland NB, Foote RL, Suman VJ (1997) Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otolog Rhinol Laryngol 106: 943–951
Beck M (2002) Lysosomale Speicherkrankheiten. In: Strohmeyer G, Stremmel W, Niederau C (Hrsg) Angeborene Stoffwechselerkrankungen. Ecomed, Landsberg, S 289–314
Beck M, Ries M (2002) Morbus Fabry. Klinische Manifestation, Diagnostik und Therapie. TKT Europe-5S Gmbh, Wachenroth
Beck M, Whybra C, Kriegsmann J (2001) Morbus Fabry. Aktuelle therapeutische Perspektiven. Dt Ärztebl 98: A 466–468 (Heft 8)
Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284: 2771–2775
Brand CU, Yawalkar N, von Briel C, Hunziker T (1996) Combined surgical and X-ray treatment for angiosarcoma of the scalp: report of a case with a favourable outcome. Br J Dermatol 134: 763–765
Breunig F, Weidemann F, Beer M, Eggert A, Krane V, Spindler M, Sandstede J, Strotmann J, Wanner C (2003) Fabry disease: diagnosis and treatment. Kidney Int Suppl 84: 181–185
Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27: 385–410
Desnick RJ, Ioannou YA, Eng CM (1995) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. 7th edition. Volume II. McGraw-Hill, New York, pp 2741–2784
Diaz-Cascajo C, de la Vega M, Rey-Lopez A (1997) Superinfected cutaneous angiosarcoma: a highly malignant neoplasm simulating an inflammatory process. J Cutan Pathol 24: 56–60
Eiling S, Lischner S, Busch JO, Rothaupt D, Christophers E, Hauschild A (2002) Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol 147: 150–153
Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L (2001) A phase 1/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 68: 711–722
Fletcher CDM (1996) Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms. Monogr Pathol 38: 181–206
Franke FE, Steger K, Marks A, Kutzner H, Mentzel T (2004) Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol 31: 362–367
Guffon N, Fouilhoux A (2004) Clinical benefit in Fabry patients given enzyme replacement therapy. A case series. J Inherit Metab Dis 27: 221–227
Guillou L, Calonje E, Speight P, Rosai J, Fletcher CDM (1999) Hobnail hemangioma. A pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma. Am J Surg Pathol 23: 97–105
Guillou L, Fletcher CDM (2000) Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi’s sarcoma. Am J Surg Pathol 24: 1047–1057
Hottenrott G, Mentzel T, Peters A, Schröder A, Katenkamp D (1999) Intravascular (“intimal”) epithelioid angiosarcoma: clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 435: 473–478
Jansen T, Bechara FG, Altmeyer P (2003) Angiokeratome. Klinik, Diagnostik und Therapie. TKT Europe-5S, Wachenroth
Lacour M, Lake BD (1995) Rapid laboratory confirmation of Fabry’s disease: a reminder. Br J Dermatol 133: 329–347
Lapidus CS, Sutula FC, Stadecker MJ, Vine JE, Grande DJ (1996) Angiosarcoma of the eyelid: yellow plaques causing ptosis. J Am Acad Dermatol 34: 308–310
Luderschmidt C, Wolff HH (1980) Heterozygoter Morbus Fabry. Fallbericht mit elektronenmikroskopischer Untersuchung. Hautarzt 31: 372–375
MacDermot KD, Holmes A, Miners AH (2001) Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 24(Suppl. 2): 14–14
Meis-Kindblom JM, Kindblom LG (1998) Angiosarcoma of soft tissue. A study of 80 cases. Am J Surg Pathol 22: 683–697
Mentzel T, Kutzner H (2002) Lymphgefäßtumoren der Haut und des Weichgewebes. Pathologe 23: 118–127
Mentzel T, Kutzner H, Wollina U (1998) Cutaneous angiosarcoma of the face: clinicopathologic and immunohistochemical study of a case resembling rosacea clinically. J Am Acad Dermatol 38: 837–840
Mentzel T, Partanen TA, Kutzner H (1999) Hobnail hemangioma („targetoid hemosiderotic hemangioma“): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol 26: 279–286
Mohrenschläger M, Braun-Falco M, Ring J, Abeck D (2003) Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 4: 189–196
Morgan MB, Swann M, Somach S, Eng W, Smoller B (2004) Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol 50: 867–874
Nuovo M, Nuovo G (2001) Utility of HHV8 RNA detection for differentiating Kaposi’s sarcoma from its mimics. J Cutan Pathol 28: 248–255
Ockenfels HM, Brockmeyer NH, Hengge UR et al. (1996) Cutaneous angiosarcoma: a novel therapy with liposomal doxorubicin. J Eur Acad Dermatol Venereol 6: 71–75
Panizzon R, Schneider BV, Schnyder UW (1990) Rosacealike angiosarcoma of the face. Dermatologica 181: 252–254
Patel RM, Goldblum JR, His ED (2004) Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Modern Pathology 17: 456–460
Rapini RP, Golitz LE (1990) Targetoid hemosiderotic hemangioma. J Cutan Pathol 17: 233–235
Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RPM, Wevers RA, Salvayre R, Levade T (1996) Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in a α-galactosidase A gene. J Med Genet 33: 682–688
Rossi S, Fletcher CD (2002) Angiosarcoma arising in hemangioma/vascular malformation: report of four cases and review of the literature. Am J Surg Pathol 26: 1319–1329
Sangueza O, Requena L (2003) Pathology of vascular skin lesions. Clinicopathologic correlations. Humana, Totowa
Santa Cruz DJ, Aronberg J (1988) Targetoid hemosiderotic hemangioma. J Am Acad Dermatol 19: 550–558
Schwartz EJ, Dorfman RF, Kohler S (2003) Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma. Am J Surg Pathol 27: 1546–1550
Spieth K, Gille J, Kaufmann R (1999) Therapeutic efficacy of interferon alfa-2a and 13-cis retinoic acid in recurrent angiosarcoma of the head. Arch Dermatol 135: 1035–1037
Tschachler E (2000) Das humane Herpesvirus Typ 8 (HHV-8). Hautarzt 51: 623–631
Wehrli BM, Janzen DL, Shokeir O, Masri BA, Byrne SK, O’Connell JX (1998) Epithelioid angiosarcoma arising in a surgically constructed arteriovenous fistula. Am J Surg Pathol 22: 1154–1159
Wilson Jones E (1976) Malignant vascular tumors. Clinical and Experimental Dermatology 1: 287–312
Wilson Jones E, Winkelmann RK, Zachary CB, Reda AM (1990) Benign lymphangioendothelioma. J Am Acad Dermatol 23: 229–235
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kutzner, H. (2005). Gefäßmissbildungen und Gefäßtumoren. In: Plewig, G., Kaudewitz, P., Sander, C.A. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28691-8_15
Download citation
DOI: https://doi.org/10.1007/3-540-28691-8_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21055-9
Online ISBN: 978-3-540-28691-2
eBook Packages: Medicine (German Language)